Notable Labs Operating Income 2013-2024 | NTBLQ

Notable Labs operating income from 2013 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Notable Labs Annual Operating Income
(Millions of US $)
2023 $-15
2022 $-13
2021 $-30
2020 $-24
2019 $-20
2018 $-21
2017 $-11
2016 $-16
2015 $-15
2014 $-15
2013 $-16
2012 $-12
Notable Labs Quarterly Operating Income
(Millions of US $)
2024-06-30 $-5
2024-03-31 $-4
2023-12-31 $-5
2023-09-30 $-1
2023-06-30 $-3
2023-03-31 $-6
2022-12-31 $17
2022-09-30 $-9
2022-06-30 $-10
2022-03-31 $-11
2021-12-31 $-9
2021-09-30 $-7
2021-06-30 $-8
2021-03-31 $-6
2020-12-31 $-7
2020-09-30 $-6
2020-06-30 $-6
2020-03-31 $-6
2019-12-31 $-6
2019-09-30 $-5
2019-06-30 $-5
2019-03-31 $-4
2018-12-31 $-4
2018-09-30 $-6
2018-06-30 $-4
2018-03-31 $-7
2017-12-31 $-8
2017-09-30 $-6
2017-06-30 $-5
2017-03-31 $-5
2016-12-31 $-5
2016-09-30 $-3
2016-06-30 $-3
2016-03-31 $-5
2015-12-31 $-3
2015-09-30 $-6
2015-06-30 $-3
2015-03-31 $-3
2014-12-31 $-5
2014-09-30 $-3
2014-06-30 $-3
2014-03-31 $-3
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00